EVs from CD63 and a sequence from Apo‐A1 fusion gene‐modified 293T cells selectively bound to HepG2 liver cancer cells via the scavenger receptor class B type 1‐Apo‐A1 complex. Here, APOA1 is linked to liver cancer.